| Ytd | -23.25% | |
| 1y | 27.42% |
| Open | 17.11 | Prev Close | 17.23 | Low | 16.77 | High | 17.15 | Mkt Cap | 1.17B |
| Vol | 2.28M | Avg Vol | 1.92M | EPS | -0.90 | P/E | N/A | Forward P/E | 98.83 |
| Beta | 1.56 | Short Ratio | 5.66 | Inst. Own | 115.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 19.54 | 200-d Avg | 19.66 | 1yr Est | 28.70 |
Tandem Diabetes Care (TNDM) was a big mover last session on higher-than-average trading volume. The
The FDA authorized Abbott's Libre Duo 10 Day, the first wearable tracking both glucose and keton
William Blair analyst Steven Lichtman initiates coverage on Tandem Diabetes Care (NASDAQ:TNDM) wi
William Blair initiates coverage on Tandem Diabetes Care and Beta Bionics, highlighting their growth